← Evidence map

ArticleApoptosis : an international journal on programmed cell death2024

Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy.

Ying Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39023830